LazelBarringtonAugustusMD
Internal Medicine • Tyler, TXGeriatric Medicine, Hospital Medicine/Hospitalist
Physician
Dr. Augustus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 S Beckham Ave
Tyler, TX 75701Phone+1 903-363-2295
Summary
- Dr. Lazel Augustus, MD, is an internal medicine specialist based in Tyler, Texas. His subspecialties include geriatric medicine and hospital medicine. Dr. Augustus completed his residency in Internal Medicine at the Bassett Medical Center between 1998 and 2000, after graduating from the University of Texas Medical Branch School of Medicine in 1997. He has contributed significantly to medical literature, with multiple publications related to cancer immunology, immunotherapy and his findings being frequently cited. His published work spans across journals such as The Kurume Medical Journal, Cancer Immunology, Cancer Biotherapy, and the International Journal of Cancer.
Education & Training
Bassett Medical CenterResidency, Internal Medicine, 1998 - 2000
University of Texas Medical Branch School of MedicineClass of 1997
Certifications & Licensure
TX State Medical License 2000 - 2025- National Board of Physicians and Surgeons Internal Medicine
Publications & Presentations
PubMed
- Increase in the Capability of Interleukin 2 Gene-Transduced Renal Cell Carcinoma Cells to Induce Cytotoxic LymphocytesKyogo Itoh, Yasuiki Umezu, Tatsuo Morita, Hideyuki Saya, Dai Seito
The Kurume Medical Journal. 1994-01-01 - 3 citationsIncrease in the ability of human cancer cells to induce cytotoxic T lymphocytes by ultraviolet irradiation.Yasuiki Umezu, Lazel B. Augustus, Dai Seito, K. Hayakawa, Merric I. Ross
Cancer Immunology, Immunotherapy. 1993-11-01 - 12 citationsCytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid)Wakae Fujimaki, Kyogo Itoh, Taeha An, Jacalyn B. Gano, Merrick I. Ross
Cancer Biotherapy. 1993-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
